CSCIED

期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

当前位置:首页 > 编委信息 > 编委详情
姜俊
职称:讲师,主治医师
单位:西京医院泌尿外科
社会任职:

个人简介

目前主要从事于前列腺癌去势抵抗型CRPC、神经内分泌型NEPC进展阶段的分子机制与临床转化研究。

教育经历

学术贡献

  • [1] Jiang Jun#,…Zhang Rui*, Han Donghui*, Qin Weijun*. LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer. Cancer Research(IF: 16.6, 第一作者. )
  • [2] Jiang Jun#, Han Donghui#, Wang Jiawei, Wen Weihong*, Zhang Rui*, Qin Weijun*, Neuroendocrine transdifferentiation in human cancer: molecular mechanisms and therapeutic targets. MedComm, 2024, 5(10):e761. (IF: 10.7, 第一作者)
  • [3] Chu Jie#, Jiang Jun#, …Bian Ka*, Yang Angang*, Zhang Rui*. A novel MYC-ZNF706-SLC7A11 regulatory circuit contributes to cancer progression and redox balance in human hepatocellular carcinoma, Cell Death & Differentiation. 2024, 31(10):1333-1348. (IF: 15.4, 共同第一)
  • [4] Jiang Jun#, …Ren Xinling, Zhang Rui*. Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases. J Nanobiotechnology, 2024, 22(1):159. (IF: 12.6, 第一作者)
  • [5] Jiang Jun#, Xu Chao#, Han Donghui#, Lu Yuan, Yang Fa, Wang Jiawei, Yan Xiaolong, Mu Xiaorong, Zhang Jipeng, Jia Chenhui, Xu Xiaorong, Liu Kui, Liu Zhenhua, Gong Li*, Wan Yi*, Lu Qiang*. Functional heterogeneity of cancer-associated fibroblasts with distinct neoadjuvant immunotherapy plus chemotherapy response in esophageal squamous cell carcinoma, Biomarker Research. 2024, 12(1):113. (IF: 11.5, 第一作者)

工作经历